Solasia Pharma KK
TSE:4597
Solasia Pharma KK
Gross Profit
Solasia Pharma KK
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Solasia Pharma KK
TSE:4597
|
Gross Profit
¥337m
|
CAGR 3-Years
11%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Gross Profit
¥22.4B
|
CAGR 3-Years
40%
|
CAGR 5-Years
40%
|
CAGR 10-Years
105%
|
|
PeptiDream Inc
TSE:4587
|
Gross Profit
¥17.2B
|
CAGR 3-Years
22%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Gross Profit
¥26.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Gross Profit
¥1.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
17%
|
S
|
StemRIM Inc
TSE:4599
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Solasia Pharma KK's Gross Profit?
Gross Profit
337m
JPY
Based on the financial report for Dec 31, 2023, Solasia Pharma KK's Gross Profit amounts to 337m JPY.
What is Solasia Pharma KK's Gross Profit growth rate?
Gross Profit CAGR 5Y
26%
Over the last year, the Gross Profit growth was -49%. The average annual Gross Profit growth rates for Solasia Pharma KK have been 11% over the past three years , 26% over the past five years .